Abstract
Blood–brain barrier restricts the uptake of many important hydrophilic drugs and limits their efficacy in the treatment of brain diseases because of the presence of tight junctions, high metabolic capacity, low pinocytic vesicular traffic, and efficient efflux mechanisms. In the present project, transferrin (Tf)-conjugated solid lipid nanoparticles (Tf-SLNs) were investigated for their ability to deliver temozolomide (TMZ) to the brain. SLNs were prepared by an ethanol injection method using hydrogenated soya phosphatidylcholine, triolein, cholesterol and distearoylphosphatidylethanolamine. Conjugation of SLNs with Tf was achieved by incubation of Tf with TMZ-loaded SLNs in the presence of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride in phosphate buffered saline (pH 7.4) as a cross linker. SLNs preparation were characterized for particle size, polydispersity index, zeta potential, surface morphology, percent drug entrapment efficiency, in vitro drug release, and hemolytic toxicity studies. In vitro cytotoxicity studies were performed on human cancer cell lines. The average size was found to be 221 ± 3.22 nm with entrapment efficiency of 69.83 ± 2.52 and 249 ± 2.61 nm with entrapment efficiency decreased to 64.21 ± 2.27 % for unconjugated SLNs and Tf-SLNs, respectively. Fluorescence studies revealed the enhanced uptake of Tf-SLNs in brain tissue compared with unconjugated SLNs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness L (1996) Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305–309
Boltri L, Canal T, Esposito PA, Carli F (1993) Lipid nanoparticles: evaluation of some critical formulation parameters. Int Symp Control Rel Bioact Mater 20:346–347
Bradford MA (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Fishman JB, Rubin JB, Handrahen JV, Connor JR, Fine RE (1987) Receptor mediated transcytosis of transferrin across the blood brain barrier. J Neurosci Res 48:299–305
Friedman HS, Kerby T, Calvert H (2000) Temozolamide and treatment of malignant glioma. Clin Cancer Res 6:2585–2597
Fry DW, White JC, Goldman ID (1978) Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem 90:803–807
Gupta Y, Soni V, Chourasia MK, Jain A, Khare P (2005) Targeted drug delivery to the brain via transferrin coupled liposomes. Drug Deliv Tech 5:66–71
Gupta Y, Jain A, Jain SK (2007) Transferrin conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 59:935–940
Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H (2004) Factors governing the in vivo tissue uptake of transferrin coupled polyethylene glycol liposomes in vivo. Int J Pharm 281:25–33
Jain A, Jain SK (2010) Transferrin coupled PEGylated nanoparticles bearing temozolomide for brain delivery and their assessment for fluorescence and confocal laser scanning microscopy. J Adv Micro Res 5:91–99
Jain A, Jain SK (2011) Drug targeting to the brain: a review. Curr Nanosci 7:21–36
Jain A, Chasoo G, Singh SK, Saxena AK, Jain SK (2011) Transferrin appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterization. J Microencap 28:21–28
Khare P, Jain A, Gulbake A, Soni V, Jain NK, Jain SK (2009) Bioconjugates: harnessing potential for effective therapeutics. Crit Rev Ther Drug Carrier Syst 26:119–155
Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K, Vyas SP (2006) Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target 14(1):45–53
Muller RH, Mehnert W, Lucks JS, Schwarz C, Zur Muhlen A, Weyhers H, Freitas C, Ruhl D (1995) Solid lipid nanoparticles (SLN) an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 41:62–69
Muller RH, Madder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur J Pharm Biopharm 50:161–177
Pardridge WM (1995) Transport of small molecules through the blood brain barrier: biology and methodology. Adv Drug Del Rev 15:5–38
Pardridge WM, Eisinberg J, Yang J (1987) Human blood–brain barrier transferrin receptor. Metabolism 36:892–895
Pardris WP (1992) Brain capillary endothelial transport of insulin. In: Simionescu N, Simionescu M (eds) Endothelial cell dysfunctions. Plenum Press, New York, pp 347–368
Qian ZM, Li H, Sun H, Ho K (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54:561–587
Roullin VG, Callewaert M, Molinari M, Delavoie F, Second A, Andry MC (2010) Optimised NSAIDS-loaded biocompatible nanoparticles. Nano-Micro Lett 2:247–255
Schwarz C, Mehnert W, Lucks JS, Muller RH (1994) Solid lipid nanoparticle (SLN) for controlled drug delivery: I production, characterization and sterilization. J Control Release 30:83–96
Shokuhfar A, Ghaffari A, Ghasemi RH (2012) Cavity control of prefoldin nanoactuator (PNA) by temperature and pH. Nano-Micro Lett 4(2):110–117
Siekmann B, Westesen K (1992) Submicron-sized parental carrier system based on solid lipids. Pharm Pharmacol Lett 1:123–126
Sjostrom B, Bergenstahl B (1992) Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm 88:53–62
Soni V, Kohli DV, Jain SK (2005) Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-fluorouracil. J Drug Target 13:245–250
Soni V, Jian A, Khare P, Gulbake A, Jain SK (2010) Potential approaches for drug delivery to the brain: Past, Present, and Future. Crit Rev Ther Drug Carrier Syst 27:187–236
Stevens PJ, Sekido M, Lee RJ (2004) Synthesis and evaluation of a hematoporphyrin derivative in a folate-targeted solid–lipid nanoparticle formulation. Anticancer Res 24:161–166
Visser CC, Stevanovic S, Heleen Voorwinden L, Gaillard PJ, Crommelin DJ, Danhof M, De Boer AG (2004) Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J Drug Target 12(3):145–150
Wagner E, Cruel D, Cotton M (1994) Delivery of drug protein and genes into cells using transferrin as a ligand for receptor mediated endocytosis. Adv Drug Del Rev 14:113–135
Acknowledgments
We are thankful to Naprod Life Sciences, Mumbai, India for gift sample of temozolomide. Financial assistance provided by M.P. Council of Science & Technology (MPCST), Bhopal, to Dr. Aviral Jain is duly acknowledged. Authors are grateful to All India Institute of Medical Sciences, New Delhi for providing Electron Microscopy facility. Dr. S.C. Lakhotiya Banaras Hindu University for helping in confocal studies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jain, A., Singhai, P., Gurnany, E. et al. Transferrin-tailored solid lipid nanoparticles as vectors for site-specific delivery of temozolomide to brain. J Nanopart Res 15, 1518 (2013). https://doi.org/10.1007/s11051-013-1518-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-013-1518-4